Abstract: A composition for synergistically increasing milk fat production in ruminants comprising (1) pellets which comprise an antacid selected from the group consisting of sodium and magnesium antacids and an electrolyte selected from the group consisting of potassium, sodium, and chlorine containing electrolytes, said pellets containing potassium, sodium, and chlorine in a weight ratio of from about 1.5 to about 1.8 parts of potassium and from about 1.2 to about 1.5 parts of chlorine per part of sodium, said potassium being present in sufficient amount to provide from about 0.8 to about 1 weight parts of potassium per weight part of any magnesium present and (2) sodium bicarbonate.

Abstract: Estriol is administered to ruminants in dosages from about 0.01-4.0 mg/ruminant/day to promote growth and increase feed utilization efficiency.

Abstract: Compounds having the formula: ##STR1## wherein R.sub.1 is hydrogen, or an alkyl from about 1 to about 3 carbon atoms; R.sub.2 is hydrogen, or an alkyl from about 1 to about 18 carbon atoms; R.sub.3 is keto, or hydroxyl; and R.sub.4 is hydrogen, an alkyl from about 1 to about 4 carbon atoms, hydroxyl, or amino are synthesized and administered to animals as anabolic agents.

Abstract: Crystallization of trimethylolethane from supersaturated aqueous solutions is inhibited in the presence of effective amounts of methanol and formic acid as crystallization inhibitors.

Abstract: The Resorcylic Acid Lactone (RAL) derivatives zearalenone, zearalanone, zearalene, zearalane, zearalenol, zearalanol, and dideoxyzearalane are administered to vertebrates to non-specifically stimulate the immune system.

Abstract: The proteins somatotropin and prolactin are administered to animals in amounts of from about 0.1-24 mg/animal/day to stimulate the immune system by increasing the production of macrophages and augmenting the oxidative metabolism of macrophages. The activated macrophages combat infectious disease causing agents such as viruses, bacteria, fungi, protozoa, helminths, and the like and thus are effective in preventing and treating diseases caused by those agents.

Abstract: Human Growth Hormone-Releasing Factor (hGRF) analogs having the sequence [X.sup.3, Y.sup.8, Z.sup.25, Nle.sup.27 ]-hGRF(1-A)--B, wherein X, Y, and Z are selected from the group consisting of Asn and Asp, A has a value from 29-44, and B is NH.sub.2 or OH are synthesized and administered to animals to stimulate the release of Growth Hormone (GH).

Abstract: A method is disclosed for increasing the fluosilicic acid (FSA) recovered from a wet process phosphoric acid manufacturing process. The filtrate obtained by washing a filter cake is pumped to a stripper and reacted with H.sub.2 SO.sub.4 to converting the dissolved FSA to gaseous SiF.sub.4. A defoamer is added to the acid-filtrate mixture to reduce the foam produced by the reaction and increase the amount of gaseous SiF.sub.4 recovered from the reaction. The gaseous SiF.sub.4 is recovered from the acid-filtrate reaction mixture and converted to FSA for commercial use.

Abstract: 6' carbonate esters of zearalanol and its derivatives are used to promote growth in ruminants. The compounds have the structural formula: ##STR1## wherein R.sub.1 and R.sub.2, which may be the same or different, are H, X, or COX, where X is an alkyl group having from 1-6 carbon atoms; and R is an alkyl group or a Br or Cl substituted alkyl group having from 1-12 carbon atoms.

Abstract: A new froth flotation collecting agent and an improved flotation process for beneficiating silica-containing ores, particularly phosphate ores, are provided. In the process, silica particles are selectively separated, by froth flotation, as a froth phase from mineral particles, particularly phosphate particles, remaining in an aqueous concentrate phase in the presence of a silica-activating ion and a mixed collecting agent containing an anionic collector and a cationic collector.